Jia-Yi Li
101 – 110 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
- Contribution to journal › Article
-
Mark
Stem cell-based therapy for Parkinson's disease.
- Contribution to journal › Scientific review
-
Mark
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.
- Contribution to journal › Article
-
Mark
Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes.
- Contribution to journal › Article
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
- Contribution to journal › Scientific review
- 2004
-
Mark
Stem cell therapy for Parkinson's disease: where do we stand?
- Contribution to journal › Scientific review
- 2003
-
Mark
Huntington's disease: a synaptopathy?
- Contribution to journal › Article
